You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 271 No. 10, March 9, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Toward Optimal Laboratory Use
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Practice Parameter for the Use of Fresh-Frozen Plasma, Cryoprecipitate, and Platelets

Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists; E. Shannon Cooper, MD; Arthur W. Bracey, MD; Andrew E. Horvath, MD; Jacob N. Shanberge, MD; Toby L. Simon, MD; David H. Yawn, MD

JAMA. 1994;271(10):777-781.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THESE guidelines have been prepared to assist the ordering physician in selecting the proper blood component for obtaining and maintaining hemostasis. While it is not possible to detail every clinical situation for which these components may be indicated, these guidelines will cover most important states. Since these guidelines were developed for adult patients, they may not apply in all cases for pediatric transfusions. Also, these guidelines do not eliminate the need for expert consultation in this complex area of medical practice, and in situations that involve very complex massive bleeding physicians may not be able to adhere to them.

It should be understood that adherence to parameters does not guarantee a successful outcome. Rather, these parameters are provided as an educational tool to assist physicians in providing quality care. If equally valid parameters or views advanced by other respected groups are applicable, the physician is, of course, free to follow . . . [Full Text PDF of this Article]


Author Affiliations

Ochsner Medical Institutions, New Orleans, La; St Luke's Episcopal Hospital, Texas Heart Institute, and University of Texas Medical School, Houston; Presbyterian Healthcare Services and University of New Mexico School of; Medicine, Albuquerque; William Beaumont Hospital, Royal Oak, Mich, and University of Michigan, Ann Arbor; Blood Systems Inc, Scottsdale, Ariz, and the University of New Mexico School of Medicine, Albuquerque; Baylor College of Medicine and The Methodist Hospital, Houston, Tex.

From the Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists (CAP), Northfield, III. A list of the members of this task force appears at the end of this article. The Practice Parameter for the Use of Fresh-Frozen Plasma, Cryoprecipitate, and Platelets was adopted by the CAP House of Delegates on October 14,1992, and the CAP Board of Governors accepted this parameter as official CAP policy on May 14, 1993.


Footnotes

Reprint requests to College of American Pathologists, 325 Waukegan Rd, Northfield, IL 60093-2750 (Barbara J. Barrett).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.